Sonova (OTCMKTS:SONVY) Sets New 12-Month High – Here’s What Happened

Sonova Holding (OTCMKTS:SONVY)’s share price hit a new 52-week high on Monday. The company traded as high as $69.66 and last traded at $69.66, with a volume of 739 shares changing hands. The stock had previously closed at $68.25.

Analysts Set New Price Targets

A number of research firms recently commented on SONVY. The Goldman Sachs Group upgraded Sonova from a “hold” rating to a “buy” rating in a research report on Thursday, October 8th. Citigroup restated a “sell” rating on shares of Sonova in a report on Friday, July 24th. Finally, UBS Group cut Sonova from a “strong-buy” rating to a “hold” rating in a report on Monday. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold”.

Sonova Trading Down 1.1%

The company’s 50 day moving average price is $61.51 and its two-hundred day moving average price is $53.34. The company has a quick ratio of 1.43, a current ratio of 1.75 and a debt-to-equity ratio of 0.51.

About Sonova

Sonova Holding AG is a Switzerland-based hearing-care company that develops, manufactures and distributes solutions for people with hearing loss. Its portfolio includes hearing aids, cochlear implants, hearing implants, wireless communication products and related accessories and services.

The company markets products under several brands, including Phonak, Unitron and Advanced Bionics. Sonova also operates hearing-care businesses and retail networks that provide hearing assessments, device fitting, rehabilitation support and after-sales services.